(Q30311257)

16 June 2017

title

Serologic response and reactogenicity to booster immunization of healthy seropositive adults with live or inactivated varicella vaccine (English)

1 reference

16 June 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1314536

12 September 2022

author name string

S. J. Sperber

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1314536

12 September 2022

B. V. Smith

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1314536

12 September 2022

F. G. Hayden

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1314536

12 September 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1314536

12 September 2022

publication date

1 March 1992

1 reference

full work available at URL

16 June 2017

https://api.elsevier.com/content/article/PII:0166354292900424?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0166-3542(92)90042-4

https://api.elsevier.com/content/article/PII:0166354292900424?httpAccept=text/plain

3 December 2023

1 reference

https://api.crossref.org/works/10.1016/0166-3542(92)90042-4

3 December 2023

1 reference

16 June 2017

volume

17

1 reference

16 June 2017

issue

3

1 reference

16 June 2017

page(s)

213-222

1 reference

Varicella vaccine studies in healthy children and adults

16 June 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0166-3542(92)90042-4

The immunogenicity of the Oka/Merck varicella vaccine in relation to infectious varicella-zoster virus and relative viral antigen content

3 December 2023

2

1 reference

https://api.crossref.org/works/10.1016/0166-3542(92)90042-4

Decrease of the lymphoproliferative response to varicella-zoster virus antigen in the aged

3 December 2023

3

1 reference

https://api.crossref.org/works/10.1016/0166-3542(92)90042-4

Live attenuated varicella vaccine

3 December 2023

5

1 reference

https://api.crossref.org/works/10.1016/0166-3542(92)90042-4

Immunization of healthy adults with live attenuated varicella vaccine

3 December 2023

6

1 reference

https://api.crossref.org/works/10.1016/0166-3542(92)90042-4

Zoster in the elderly: clinical, immunologic and therapeutic considerations

3 December 2023

7

1 reference

https://api.crossref.org/works/10.1016/0166-3542(92)90042-4

Live attenuated varicella vaccine in healthy 12- to 24-month-old children

3 December 2023

8

1 reference

https://api.crossref.org/works/10.1016/0166-3542(92)90042-4

Selective decline in cellular immune response to varicella-zoster in the elderly

3 December 2023

9

1 reference

https://api.crossref.org/works/10.1016/0166-3542(92)90042-4

Nosocomial varicella: worth preventing, but how?

3 December 2023

10

1 reference

https://api.crossref.org/works/10.1016/0166-3542(92)90042-4

Antibody assays suitable for assessing immune responses to live varicella vaccine

3 December 2023

11

1 reference

https://api.crossref.org/works/10.1016/0166-3542(92)90042-4

Enzyme-Linked Immunosorbent Assay for Susceptibility to Varicella

3 December 2023

12

1 reference

https://api.crossref.org/works/10.1016/0166-3542(92)90042-4

Live attenuated varicella virus vaccine. Efficacy trial in healthy children

3 December 2023

14

1 reference

https://api.crossref.org/works/10.1016/0166-3542(92)90042-4

3 December 2023

Identifiers

1 reference

16 June 2017

1 reference